Treatment of infections associated with surgical implants.
暂无分享,去创建一个
[1] G. Sirchia,et al. Fresh and Cryopreserved Arterial Homografts in the Treatment of Prosthetic Graft Infections: Experience of the Italian Collaborative Vascular Homograft Group , 1998, Annals of vascular surgery.
[2] A. Lumsden,et al. Management of infected hemodialysis access grafts using cryopreserved human vein allografts. , 2002, American journal of surgery.
[3] A. Hanssen,et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] U. Steger,et al. Surgical management of prosthetic vascular graft infection: comparative retrospective analysis of 30 consecutive cases. , 2002, VASA. Zeitschrift fur Gefasskrankheiten.
[5] Claude Carbón,et al. Prosthetic joint infection: when can prosthesis salvage be considered? , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[6] J. Mulcahy. Surgical management of penile prosthesis complications , 2000, International Journal of Impotence Research.
[7] R. Swanton,et al. Mortality from infective endocarditis: clinical predictors of outcome , 2002, Heart.
[8] R. Darouiche. Antimicrobial approaches for preventing infections associated with surgical implants. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] J. Ruskin,et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. , 2001, The American journal of cardiology.
[10] G. Moneta,et al. Improved results with conventional management of infrarenal aortic infection. , 1999, Journal of vascular surgery.
[11] G. Cooper,et al. Effect of temperature on the Brugada ECG , 2003, Heart.
[12] B. Browne,et al. Cerebral ventricular shunts. , 1999, The Journal of emergency medicine.
[13] P. Kreienberg,et al. Alternative approach for management of infected aortic grafts. , 1997, Journal of vascular surgery.
[14] J. A. Nelson,et al. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] M C Oz,et al. Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.
[16] J. Costerton,et al. Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.
[17] D Lacroix,et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. , 1997, Circulation.
[18] R. Grimer,et al. Two-Stage Revision for Infected Endoprostheses Used in Tumor Surgery , 2002, Clinical orthopaedics and related research.
[19] Richard A. Lange,et al. Prosthetic heart valves. , 1996, The New England journal of medicine.
[20] S. Wilson,et al. Inflatable penile implant infection: predisposing factors and treatment suggestions. , 1995, The Journal of urology.
[21] P L Hibberd,et al. Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] M. Oz,et al. Infections During Left Ventricular Assist Device Support Do Not Affect Posttransplant Outcomes , 2000, Circulation.
[23] M. Dan,et al. Successful Management of an Infected Implantable Cardioverter Defibrillator with Oral Antibiotics and without Removal of the Device , 1997, Pacing and clinical electrophysiology : PACE.
[24] J. Coselli,et al. Management of thoracic aortic graft infections. , 1999, The Annals of thoracic surgery.
[25] Y. Ouchi,et al. Changing spectrum of infective endocarditis: review of 194 episodes over 20 years. , 2003, Circulation journal : official journal of the Japanese Circulation Society.
[26] R. Wittler,et al. Treatment of cerebrospinal fluid shunt infections: a decision analysis , 2002, The Pediatric infectious disease journal.
[27] A. Widmer. New developments in diagnosis and treatment of infection in orthopedic implants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] W M O'Fallon,et al. Complications leading to surgery after breast implantation. , 1997, The New England journal of medicine.
[29] M C Oz,et al. Implantable left ventricular assist devices. , 1998, The New England journal of medicine.
[30] D. Sexton,et al. The Impact of Surgical-Site Infections Following Orthopedic Surgery at a Community Hospital and a University Hospital Adverse Quality of Life, Excess Length of Stay, and Extra Cost , 2002, Infection Control & Hospital Epidemiology.
[31] W. Whitehead,et al. The Treatment of Cerebrospinal Fluid Shunt Infections , 2001, Pediatric Neurosurgery.
[32] B. Morrey,et al. Treatment of Infection with Débridement and Retention of the Components following Hip Arthroplasty* , 1998, The Journal of bone and joint surgery. American volume.
[33] Randolph P. Martin,et al. The Role of Transesophageal Echocardiography in the Diagnosis and Management of Patients with Aortic Perivalvular Abscesses , 2001, The American journal of the medical sciences.
[34] R. Darouiche. Device-associated infections: a macroproblem that starts with microadherence. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] J. Drake,et al. Repeat Cerebrospinal Fluid Shunt Infection in Children , 2001, Pediatric Neurosurgery.
[36] L. Reilly. Aortic Graft Infection: Evolution in Management , 2002, Cardiovascular surgery.
[37] J. Kestle,et al. Ventricular shunting for hydrocephalus in children: patients, procedures, surgeons and institutions in English Canada, 1989-2001. , 2002, European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie.
[38] F. Isobe,et al. Early and late outcomes after reoperation for prosthetic valve endocarditis. , 2001, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.
[39] J. Christenson,et al. Aorto-Enteric Fistula is a Serious Complication to Aortic Surgery. Modern Trends in Diagnosis and Therapy , 2003, Cardiovascular surgery.
[40] H. Boxma,et al. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch Trauma Trial , 1996, The Lancet.
[41] P. McCarthy,et al. Implantable LVAD infections: implications for permanent use of the device. , 1996, The Annals of thoracic surgery.
[42] P. McCarthy,et al. Infections in Implantable Cardioverter Defibrillator Patients , 1990, Pacing and clinical electrophysiology : PACE.
[43] T. Ferguson,et al. The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations. , 1996, The Journal of thoracic and cardiovascular surgery.
[44] J. Costerton,et al. Bacterial biofilms: a common cause of persistent infections. , 1999, Science.
[45] E. Wong,et al. Staphylococcus aureus and Other Bacteremias in Hemodialyis Patients: Antibiotic Therapy and Surgical Removal of Access Site , 2000, Infection.
[46] P E Ochsner,et al. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. , 1998, JAMA.
[47] R. Hye,et al. Management of infectious and cutaneous complications in vascular access. , 1997, Seminars in Vascular Surgery.
[48] A. Hanssen,et al. Outcome of penicillin-susceptible streptococcal prosthetic joint infection treated with debridement and retention of the prosthesis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[49] D. Raoult,et al. Ambulatory Treatment of Multidrug-ResistantStaphylococcus-Infected Orthopedic Implants with High-Dose Oral Co-trimoxazole (Trimethoprim-Sulfamethoxazole) , 1998, Antimicrobial Agents and Chemotherapy.